§ 822a. Prescription drug take back expansion
826 words·~4 min read·
/usc/title-21/section-822aA research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Definition of covered entity In this section, the term “covered entity” means—
(1)a State, local, or tribal law enforcement agency;
(2)a manufacturer, distributor, or reverse distributor of prescription medications;
(3)a retail pharmacy;
(4)a registered narcotic treatment program;
(5)a hospital or clinic with an onsite pharmacy;
(6)an eligible long-term care facility; or
(7)any other entity authorized by the Drug Enforcement Administration to dispose of prescription medications.
(b)Program authorized The Attorney General, in coordination with the Administrator of the Drug Enforcement Administration, the Secretary of Health and Human Services, and the Director of the Office of National Drug Control Policy, shall coordinate with covered entities in expanding or making available disposal sites for unwanted prescription medications.
(Pub. L. 114–198, title II, § 203, July 22, 2016, 130 Stat. 717.)
Connections15 cite this · traces to 3
Cited by 15 sections · top 13
public-private-law
statute-compilations
statutes-at-large
- Public Law 114–198To authorize the Attorney General and Secretary of Health and Human Services to award grants to address the prescription opioid abuse and heroin use crisis, and for other purposes
- Public Law 115–271To provide for opioid use disorder prevention, recovery, and treatment, and for other purposes
Traces to 3 documents
3 references not yet in our index
- 130 Stat. 717
- 139 Stat. 678
- 132 Stat. 3950
Citation graph
cites case law
§ 822a
Prescription drug take back expansion
Bills×4
Pub. L.×4
Stat. Comp.×4
Stat.×3
Stat.130 Stat. 717
Stat.139 Stat. 678
Stat.132 Stat. 3950
Cites 6Cited by 15 across 4 sources